Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Solas Capital Management, LLC reported a 5.40% stake in Fennec Pharmaceuticals Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Solas Capital Management, LLC reported a 5.40% stake in Fennec Pharmaceuticals Inc., 1,889,366 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
5.40%
Shares
1,889,366
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Solas Capital Management, LLC5.40%1,889,366
FREDERICK TUCKER GOLDEN5.40%1,889,366

Source

View original at SEC

Related